申请人:——
公开号:US20030232810A1
公开(公告)日:2003-12-18
Described are heterocycle-substituted cyclohexylamines of formula (I), and their pharmaceutically acceptable salts thereof. The compounds of formula (I) are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.
1
描述了公式(I)的杂环取代环己胺及其药用盐。公式(I)的化合物是NMDA受体通道复合物的拮抗剂,可用于治疗脑血管疾病,例如脑缺血、心脏骤停、中风和帕金森病。